The store will not work correctly when cookies are disabled.
Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway.
Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway.
Copyright © 2025 by STEMCELL Technologies. All rights reserved.